HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 614 filers reported holding HORIZON THERAPEUTICS PUB L in Q1 2022. The put-call ratio across all filers is 0.63 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $108,177,901 | +11.4% | 935,067 | -1.0% | 0.03% | +10.7% |
| Q2 2023 | $97,142,237 | -4.3% | 944,504 | +1.5% | 0.03% | -9.7% |
| Q1 2023 | $101,557,717 | -1.9% | 930,527 | +2.3% | 0.03% | -6.1% |
| Q4 2022 | $103,512,139 | +78.2% | 909,597 | -3.1% | 0.03% | +57.1% |
| Q3 2022 | $58,090,000 | -19.0% | 938,599 | +4.4% | 0.02% | -16.0% |
| Q2 2022 | $71,715,000 | -13.3% | 899,128 | +14.3% | 0.02% | 0.0% |
| Q1 2022 | $82,737,000 | -1.2% | 786,397 | +1.2% | 0.02% | 0.0% |
| Q4 2021 | $83,748,000 | -0.6% | 777,169 | +1.0% | 0.02% | -10.7% |
| Q3 2021 | $84,291,000 | +13.8% | 769,497 | -2.8% | 0.03% | +12.0% |
| Q2 2021 | $74,101,000 | +3.2% | 791,331 | +1.4% | 0.02% | -3.8% |
| Q1 2021 | $71,815,000 | +26.7% | 780,255 | +0.7% | 0.03% | +18.2% |
| Q4 2020 | $56,685,000 | -7.1% | 774,913 | -1.4% | 0.02% | -21.4% |
| Q3 2020 | $61,025,000 | -30.6% | 785,587 | -50.3% | 0.03% | -34.9% |
| Q2 2020 | $87,877,000 | +85.5% | 1,581,073 | -1.1% | 0.04% | +53.6% |
| Q1 2020 | $47,366,000 | -20.5% | 1,599,106 | -2.8% | 0.03% | -12.5% |
| Q4 2019 | $59,553,000 | +37.4% | 1,645,088 | +3.3% | 0.03% | +23.1% |
| Q3 2019 | $43,353,000 | +57.3% | 1,592,076 | +38.9% | 0.03% | +52.9% |
| Q2 2019 | $27,569,000 | – | 1,145,830 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |